Exhibit 107

Calculation of Filing Fee Tables

Form S-1

(Form Type)

Aptevo Therapeutics Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

Security
Type

Security
Class

Title(1)

Fee

Calculation

or Carry

Forward

Rule

Amount

Registered

Proposed

Maximum

Offering

Price

Per

Unit

Maximum

Aggregate

Offering

Price(2)(5)

Fee Rate

Amount of

Registration

Fee

Fees to Be Paid

Equity

Common stock, par value $0.001 per share(3)

Rule 457(o)

$

8,000,000

0.00015310

$

1,225.00

Other

Pre-funded warrants to purchase common stock(3)(4)

Rule 457(g)

Included above

Other

Common warrants to purchase common stock(4)

Rule 457(g)

Equity

Common stock issuable upon exercise of the common warrants(5)

Rule 457(o)

$

40,000,000

0.00015310

$

6,124.00

Equity

Common stock issuable upon exercise of the pre-funded warrants(4)

Rule 457(o)

Included above

Fees Previously Paid

Carry Forward Securities

 Total Offering Amounts

$

48,000,000

0.00015310

$ 7,349.00

 Total Fees Previously Paid

 Total Fee Offsets

 Net Fee Due

$ 7,349.00

(1)

Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), there are also being registered such additional securities that may be issued because of events such as recapitalizations, stock dividends, stock splits and reverse stock splits, and similar transactions.

(2)

Estimated solely for the purpose of determining the amount of the registration fee in accordance with Rule 457(o) under the Securities Act.

(3)

The proposed maximum aggregate offering price of the shares of common stock proposed to be sold in the offering will be reduced on a dollar-for-dollar basis based on the aggregate offering price of the pre-funded warrants offered and sold in the offering (plus the aggregate exercise price of the shares of common stock issuable upon exercise of the pre-funded warrants), and as such the proposed aggregate maximum offering price of the shares of common stock and pre-funded warrants (including shares of common stock issuable upon exercise of the pre-funded warrants), if any, is $8,000,000.

(4)

No fee due pursuant to Rule 457(g) under the Securities Act because the warrants are being registered in the same registration statement as the common stock issuable upon exercise of the warrants.

 

(5)

There will be issued five common warrants, each to purchase one share of common stock, for every share of common stock being offered in this offering. As estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act, the proposed maximum offering price of shares of common stock issuable upon exercise of the common warrants proposed to be sold in the offering is $40,000,000, which is equal to 500% of $8,000,000, as each share of common stock and pre-funded warrant is being offered with five common warrants, each to purchase one share of common stock at an exercise price equal to 100% of the purchase price per share of common stock.